Skip to main content
Log in

Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro

  • Rapid Communications
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Omeprazole has been previously shown to block gastric acid secretion by specific inhibition of gastric parietal cell membrane H+−K+-ATPase. It is now demonstrated that similar concentrations of omeprazole will inhibit PGE2- and PTH-stimulated Ca++ release from prelabelled neonatal mouse calvariae without affecting the viability of cultured calvaria explants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Baron, R., Neff, L., Louvard, D., and Courtoy, P. J.: Specific localization of a lysosomal membrane protein related to a proton pump at the ruffled border of osteoclasts. Cell Biol. 97: 416a, 1983.

    Article  Google Scholar 

  2. Fellenius, E., Berglindh, T., Sachs, G., Olbe, L., Elander, B., Sjöstrand, S-E., and Wallmark, B.: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+K+) ATPase. Nature 290: 159–161, 1981.

    Article  CAS  PubMed  Google Scholar 

  3. Larsson, H., Carlsson, E., Junggren, U., Olbe, L., Sjöstrand, S. E., Skånberg, I., and Sundell, G.: Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85: 900–907, 1983.

    CAS  PubMed  Google Scholar 

  4. Wallmark, B., Jaresten, B-M., Larsson, H., Ryberg, B., Brändström, A., and Fellenius, E.: Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN on gastric acid secretion. Am. J. Physiol. 245: G64–71, 1983.

    CAS  PubMed  Google Scholar 

  5. Wollin, A.: Carbonic anhydrase activity and aminopyrine uptake in isolated gastric mucosal cells: Am. J. Physiol. 247: 213–219, 1984.

    Google Scholar 

  6. Minkin, C., Jennings, J. M.: Carbonic anhydrase and bone remodelling: Sulfonamide inhibition of bone resorption in organ culture. Science 176: 1031–1033, 1972.

    Article  CAS  PubMed  Google Scholar 

  7. Gay, C. V., Muller, W. J.: Carbonic anhydrase and osteoclasts: Localization by labelled inhibitor autoradiography. Science 183: 432–434, 1974.

    Article  CAS  PubMed  Google Scholar 

  8. Väänänen, H. K., and Parvinen, E-K.: High active isoenzyme of carbonic anhydrase in rat calvaria osteoclasts. Histochemistry 78: 481–485, 1983.

    Article  PubMed  Google Scholar 

  9. Väänänen, H. K.: Immunohistochemical localization of carbonic anhydrase isoenzymes I and II in human bone, cartilage and giant cell tumor. Histochemistry 81: 485–487, 1984.

    Article  PubMed  Google Scholar 

  10. Spicer, S. S., Sens, M. A., Hennigar, R. A., Stoward, P. J.: Implications of the immunohistochemical localization of carbonic anhydrase isoenzymes for their function in normal and pathologic cells. Ann. N. Y. Acad. Sci. 429: 382–397, 1984.

    Article  CAS  PubMed  Google Scholar 

  11. Sly, W. S., Hewett-Emmett, D., Whyle, M. P., Yu, Y. S., Tashian, R. E.: Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc. Natl. Acad. Sci. 80: 2752–2756, 1983.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Paul, F., Neumann, F., Huchzermeyer, H.: Response of basal and pentagastrin-stimulated gastric secretion and of serum gastrin to short-and long-term intravenous infusion of salmon calcitonin in hyperchlorhydric subjects. Scand. J. Gastroentrol. 13: 959–967, 1978.

    Article  CAS  Google Scholar 

  13. Ito, H., Sakurada, T., Orimo, H.: Role of endogenous calcitonin in the secretion of gastrin and gastric acid in rats. Horm. Metab. Res. 9: 89–92, 1977.

    Article  CAS  PubMed  Google Scholar 

  14. Mollerup, C., Cartensen, H. E., Bruun, E., Christiansen, L. A., Stage, G.: Possible antagonists to gastrin in parathyroid adenomas. Br. J. Surg. 67: 890–892, 1980.

    Article  CAS  PubMed  Google Scholar 

  15. Reynolds, J. J.: Organ cultures of bone: Studies on the physiology and pathology of resorption. In: Organ Culture in Biomedical Research (Bulls, M., and Monnickendam M.A., eds.) Cambridge University Press, Cambridge pp. 355–366, 1976.

    Google Scholar 

  16. Klein, D. C., and Raisz, L. G.: Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinology 86: 1436–1440, 1970.

    Article  CAS  PubMed  Google Scholar 

  17. Im, W. B., Sih, J. C., Blakeman, D. P., McGrath, J. P.: Omeprazole, a specific inhibitor of gastric (H+−K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups. J. Biol. Chem. 260: 8: 4591–4597, 1985.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by grants from Aaltonen Foundation and Paulo Foundation, Finland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tuukkanen, J., Väänänen, H.K. Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro . Calcif Tissue Int 38, 123–125 (1986). https://doi.org/10.1007/BF02556841

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02556841

Key words

Navigation